These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24708667)
1. Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. Butterfield LH; Economou JS; Gamblin TC; Geller DA J Transl Med; 2014 Apr; 12():86. PubMed ID: 24708667 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression. Rodríguez MM; Ryu SM; Qian C; Geissler M; Grimm C; Prieto J; Blum HE; Mohr L Hum Gene Ther; 2008 Jul; 19(7):753-9. PubMed ID: 18549308 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer. Butterfield LH; Ribas A; Potter DM; Economou JS Cancer Immunol Immunother; 2007 Dec; 56(12):1931-43. PubMed ID: 17522860 [TBL] [Abstract][Full Text] [Related]
6. Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo. Liu Y; Butterfield LH; Fu X; Song Z; Zhang X; Lu C; Ding G; Wu M Int J Oncol; 2011 Jul; 39(1):245-53. PubMed ID: 21491085 [TBL] [Abstract][Full Text] [Related]
7. Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma. Saeki A; Nakao K; Nagayama Y; Yanagi K; Matsumoto K; Hayashi T; Ishikawa H; Hamasaki K; Ishii N; Eguchi K Int J Mol Med; 2004 Jan; 13(1):111-6. PubMed ID: 14654980 [TBL] [Abstract][Full Text] [Related]
8. Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70. Wang XP; Liu GZ; Song AL; Li HY; Liu Y World J Gastroenterol; 2004 Nov; 10(21):3197-200. PubMed ID: 15457574 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen. Haq K; Jia Y; Elahi SM; MacLean S; Akache B; Gurnani K; Chattopadhyay A; Nazemi-Moghaddam N; Gilbert R; McCluskie MJ; Weeratna RD Vaccine; 2019 Nov; 37(47):7029-7040. PubMed ID: 31506193 [TBL] [Abstract][Full Text] [Related]
10. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448 [TBL] [Abstract][Full Text] [Related]
11. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
12. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401 [TBL] [Abstract][Full Text] [Related]
13. Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer. Liu Y; Daley S; Evdokimova VN; Zdobinski DD; Potter DM; Butterfield LH J Immunol; 2006 Jul; 177(1):712-21. PubMed ID: 16785570 [TBL] [Abstract][Full Text] [Related]
14. Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine. Bei R; Mizejewski GJ Curr Mol Med; 2011 Oct; 11(7):564-81. PubMed ID: 21707514 [TBL] [Abstract][Full Text] [Related]
15. Specific antitumor immunity induced by cross-linking complex heat shock protein 72 and alpha-fetoprotein. Wang XP; Lin HP; Wang QX; Gu Y Cancer Biother Radiopharm; 2012 Apr; 27(3):189-97. PubMed ID: 22372558 [TBL] [Abstract][Full Text] [Related]
16. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells. Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295 [TBL] [Abstract][Full Text] [Related]
17. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma. Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957 [TBL] [Abstract][Full Text] [Related]
18. Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy. Zhu W; Peng Y; Wang L; Hong Y; Jiang X; Li Q; Liu H; Huang L; Wu J; Celis E; Merchen T; Kruse E; He Y Hepatology; 2018 Aug; 68(2):574-589. PubMed ID: 29443377 [TBL] [Abstract][Full Text] [Related]
19. A DNA vaccine against chimeric AFP enhanced by HSP70 suppresses growth of hepatocellular carcinoma. Lan YH; Li YG; Liang ZW; Chen M; Peng ML; Tang L; Hu HD; Ren H Cancer Immunol Immunother; 2007 Jul; 56(7):1009-16. PubMed ID: 17186291 [TBL] [Abstract][Full Text] [Related]